Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JTX-2011
JTX-2011
Jounce seeking tumor-agnostic approach for ICOS agonist
BioCentury
Sat, 03/9/19 - 12:18 pm
Jounce Therapeutics
ICOS agonist
JTX-2011
ASCO18: Jounce plummets further on weak efficacy data
Biopharma Dive
Mon, 06/4/18 - 10:16 pm
Jounce Therapeutics
ASCO 2018
JTX-2011
solid tumors
5 takeaways from the first look at cancer's biggest conference
Biopharma Dive
Thu, 05/17/18 - 10:44 pm
ASCO
Regeneron
cemiplimab
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
Nektar
NKTR-214
Loxo Oncology
LOXO-292
Jounce Therapeutics
JTX-2011
Data from trials could send these clinical-stage biotech stocks soaring or crashing
Motley Fool
Mon, 02/5/18 - 08:26 am
clinical trials
biotech
Summit Therapeutics
DMD
Jounce Therapeutics
JTX-2011
TG Therapeutics
ublituximab
Here's a Biotech IPO You'll Want to Watch
Motley Fool
Mon, 01/9/17 - 10:11 am
biotech
IPOs
Jounce Therapeutics
Celgene
JTX-2011